General
|
RAC |
Re:
General Comments / Chat
|
|
sk1ns1
|
10K |
3.6M |
14 |
02/04/23 |
02/04/23 |
General
|
10K
|
3.6M
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
sk1ns1
|
2.8K |
953K |
47 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
2.8K
|
953K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
sk1ns1
|
1.6K |
564K |
7 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
1.6K
|
564K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
sk1ns1
|
10K |
3.6M |
15 |
23/03/23 |
23/03/23 |
General
|
10K
|
3.6M
|
15
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
sk1ns1
|
161 |
53K |
1 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
161
|
53K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
sk1ns1
|
20K |
6.8M |
19 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
20K
|
6.8M
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First In Human Patient 6 Month Study Follow Up
|
|
sk1ns1
|
71 |
21K |
7 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
71
|
21K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First In Human Patient 6 Month Study Follow Up
|
|
sk1ns1
|
71 |
21K |
4 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
71
|
21K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
sk1ns1
|
2.0K |
656K |
12 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
2.0K
|
656K
|
12
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
sk1ns1
|
2.1K |
622K |
4 |
01/01/22 |
01/01/22 |
ASX - By Stock
|
2.1K
|
622K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race raises $29.7 million in oversubscribed SPP
|
|
sk1ns1
|
378 |
98K |
58 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
378
|
98K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race raises $29.7 million in oversubscribed SPP
|
|
sk1ns1
|
378 |
98K |
27 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
378
|
98K
|
27
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
sk1ns1
|
2.1K |
622K |
4 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
2.1K
|
622K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
sk1ns1
|
10K |
3.6M |
31 |
16/12/21 |
16/12/21 |
General
|
10K
|
3.6M
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
sk1ns1
|
386 |
131K |
33 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
386
|
131K
|
33
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
sk1ns1
|
103 |
28K |
21 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
103
|
28K
|
21
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Gets Ethics Approval To Start Phase 1 Intravenous Clinical Trial
|
|
sk1ns1
|
43 |
12K |
8 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
43
|
12K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Gets Ethics Approval To Start Phase 1 Intravenous Clinical Trial
|
|
sk1ns1
|
43 |
12K |
10 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
43
|
12K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: AGM Presentation
|
|
sk1ns1
|
21 |
6.2K |
6 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
21
|
6.2K
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
sk1ns1
|
30K |
15M |
6 |
22/11/21 |
22/11/21 |
Charts
|
30K
|
15M
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
sk1ns1
|
30K |
15M |
4 |
22/11/21 |
22/11/21 |
Charts
|
30K
|
15M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
sk1ns1
|
30K |
15M |
1 |
22/11/21 |
22/11/21 |
Charts
|
30K
|
15M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
sk1ns1
|
10K |
3.6M |
0 |
06/11/21 |
06/11/21 |
General
|
10K
|
3.6M
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
sk1ns1
|
10K |
3.6M |
38 |
06/11/21 |
06/11/21 |
General
|
10K
|
3.6M
|
38
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Court application and delayed cleansing notice
|
|
sk1ns1
|
32 |
9.4K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
32
|
9.4K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Court application and delayed cleansing notice
|
|
sk1ns1
|
32 |
9.4K |
2 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
32
|
9.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading halt
|
|
sk1ns1
|
20 |
6.3K |
4 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
20
|
6.3K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Pause in Trading
|
|
sk1ns1
|
23 |
5.7K |
4 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
23
|
5.7K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
sk1ns1
|
2.1K |
622K |
7 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
sk1ns1
|
2.1K |
622K |
6 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
6
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
sk1ns1
|
2.1K |
622K |
10 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
10
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
sk1ns1
|
2.1K |
622K |
10 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
2.1K
|
622K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
sk1ns1
|
20K |
6.8M |
28 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
20K
|
6.8M
|
28
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Change in substantial holding
|
|
sk1ns1
|
77 |
23K |
5 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
77
|
23K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Change in substantial holding
|
|
sk1ns1
|
77 |
23K |
2 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
77
|
23K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Change in substantial holding
|
|
sk1ns1
|
77 |
23K |
15 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
77
|
23K
|
15
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Change in substantial holding
|
|
sk1ns1
|
77 |
23K |
10 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
77
|
23K
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
sk1ns1
|
30K |
15M |
11 |
16/08/21 |
16/08/21 |
Charts
|
30K
|
15M
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in USA for RECCE Anti-Infectives
|
|
sk1ns1
|
85 |
24K |
1 |
07/08/21 |
07/08/21 |
ASX - By Stock
|
85
|
24K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in China
|
|
sk1ns1
|
55 |
15K |
4 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
55
|
15K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in China
|
|
sk1ns1
|
55 |
15K |
3 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
55
|
15K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in China
|
|
sk1ns1
|
55 |
15K |
4 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
55
|
15K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in China
|
|
sk1ns1
|
55 |
15K |
5 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
55
|
15K
|
5
|
|
ASX - General
|
Biotech |
Re:
Ritzy - May 2021
|
|
sk1ns1
|
20 |
6.7K |
1 |
09/06/21 |
09/06/21 |
ASX - General
|
20
|
6.7K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
sk1ns1
|
20K |
6.8M |
19 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
20K
|
6.8M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
RAC Primer
|
|
sk1ns1
|
521 |
192K |
6 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
521
|
192K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC Primer
|
|
sk1ns1
|
521 |
192K |
15 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
521
|
192K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
sk1ns1
|
22K |
10M |
3 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
22K
|
10M
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
sk1ns1
|
30K |
15M |
2 |
28/05/21 |
28/05/21 |
Charts
|
30K
|
15M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
sk1ns1
|
30K |
15M |
1 |
28/05/21 |
28/05/21 |
Charts
|
30K
|
15M
|
1
|
|